Milatuzumab

From Self-sufficiency
Jump to: navigation, search
Milatuzumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target CD74
Identifiers
CAS Number 899796-83-9
ATC code none
Chemical data
Formula C6518H10066N1758O2020S40
Molar mass 146.7 kDa[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Milatuzumab is a monoclonal antibody for the treatment of multiple myeloma and other hematological malignancies.[1]

This drug was developed by Immunomedics, Inc.

References

  1. Statement On A Nonproprietary Name Adopted By The Usan Council – Milatuzumab, American Medical Association.